Trial Profile
Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis: an Open, Randomized, Controlled Clinical Trial
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 29 Jul 2015
Price :
$35
*
At a glance
- Drugs Daptomycin (Primary) ; Meropenem (Primary) ; Ceftazidime
- Indications Bacterial peritonitis; Nosocomial infections
- Focus Therapeutic Use
- 25 Oct 2011 New trial record